Travis Kanaly
Neurology · Edmond, OKNPI 1750594099
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.3% of the total across 142 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 10.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,018 and has fallen 98.6% since, to $28 in 2023.
Across 142 payments — averaging $16.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$242
- MDD US Operations, LLC$217
- Sunovion Pharmaceuticals Inc.$189
- AbbVie$162
- Supernus Pharmaceuticals, Inc.$161
- UCB, Inc.$129
- plus $1K from 23 others
What the payments were for
- Speaking & faculty fees$492%
- Food & beverage$2,22297%
- Education$131%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 16 | $242 |
| MDD US Operations, LLC | 8 | $217 |
| Sunovion Pharmaceuticals Inc. | 17 | $189 |
| AbbVie(2 entities) | 9 | $162 |
| Supernus Pharmaceuticals, Inc. | 13 | $161 |
| UCB, Inc. | 9 | $129 |
| Sanofi | 6 | $118 |
| Livanova USA, Inc. | 6 | $116 |
| Lundbeck LLC | 5 | $100 |
| Mallinckrodt Enterprises LLC | 4 | $77 |
| Genentech USA, Inc. | 4 | $74 |
| Vertical Pharmaceuticals, LLC | 4 | $72 |
| Amgen | 4 | $68 |
| Biogen | 4 | $58 |
| Lilly USA, LLC | 4 | $57 |
| EMD Serono, Inc. | 3 | $56 |
| Acorda Therapeutics, Inc | 3 | $49 |
| Eisai Inc. | 3 | $48 |
| Avanir Pharmaceuticals, Inc. | 3 | $45 |
| Promius Pharma LLC | 3 | $45 |
| Upsher-smith Laboratories LLC | 2 | $38 |
| AstraZeneca | 2 | $35 |
| Amneal Pharmaceuticals LLC | 2 | $27 |
| Neurocrine Biosciences, Inc. | 2 | $25 |
| Teva Pharmaceuticals USA, Inc. | 2 | $23 |
| Adamas Pharmaceuticals, Inc. | 1 | $19 |
| Zogenix Inc. | 1 | $13 |
| Acadia Pharmaceuticals Inc | 1 | $12 |
| Travere Therapeutics, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,283 in reported general payments places this provider in the 55th percentile of 152 neurology providers in Oklahoma.
Other neurology in Edmond
- J RosenhamerEdmond$21K
- Cherian KarunapuzhaOklahoma City$4.1M
- Gabriel PardoOklahoma City$1.5M
- Jaclyn DuvallTulsa$1.4M
- Gregory ConnorTulsa$444K
- Brett DeesNorman$420K
- Eduardo de SousaMoore$393K
- Tania ReynaTulsa$353K
- Marguerite ButcheeOklahoma City$324K
- Chelsea BerkleyOklahoma City$277K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.